Skip to main content

The only FDA-approved oral formulation for inflammatory lesions of rosacea with a precise formulation for a non-antibiotic dose2,3

Doxycycline 100 mg induced microbial resistance as early as 7 days6

  • Every year in the United States 2 million people are infected with bacteria that are resistant to antibiotics4

  • Doxycycline accounts for nearly out of 3 tetracycline prescriptions—the most commonly prescribed antibiotics5

  • Microbial resistance occurred in 7 days with doxycycline 100 mg/day6

  • Non-antibiotic dose ORACEA Capsules remained below the antimicrobial threshold1,3

  • There are no clinical studies to demonstrate additional anti-inflammatory effects of Doxycycline above 40 mg in rosacea patients

Return to Tolerability